Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient’s heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
तुलना करने के लिए मीट्रिक्स | EW | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधEWपीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | 26.7x | −6.5x | −0.6x | |
PEG अनुपात | 3.46 | −0.17 | 0.00 | |
क़ीमत/बुक | 5.5x | 3.7x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 6.6x | 2.7x | 3.2x | |
अपसाइड (विश्लेषक लक्ष्य) | 9.9% | 15.7% | 48.5% | |
उचित मूल्य अपसाइड | अनलॉक करें | −14.6% | 7.8% | अनलॉक करें |